BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 17 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 17 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 17 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 18 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 18 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 19 hours ago Atmus Welcomes Heath Sharp to Board of Directors 21 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 21 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 17 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 17 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 17 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 18 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 18 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 19 hours ago Atmus Welcomes Heath Sharp to Board of Directors 21 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 21 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

ImmunoGen Inc (IMGN) Q1 2023 Earnings Call Transcript

ImmunoGen Inc (NASDAQ:IMGN) Q1 2023 Earnings Call dated Apr. 28, 2023. Corporate Participants: Anabel Chan — Head, Investor Relations Mark Enyedy — President & Chief Executive Officer Anna Berkenblit — Senior…

ImmunoGen Inc (IMGN) Q4 2022 Earnings Call Transcript

ImmunoGen Inc (NASDAQ:IMGN) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Anabel Chan — Head of Investor Relations Mark Enyedy — President and Chief Executive Officer Anna…

ImmunoGen, Inc. (IMGN) Q1 2022 Earnings Call Transcript

ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications Mark Enyedy — President & Chief Executive…

ImmunoGen, Inc. (IMGN) FY 2021 Earnings Call Transcript

ImmunoGen, Inc.  (NASDAQ: IMGN) FY 2021 earnings call dated Feb. 25, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…

ImmunoGen Inc. (IMGN) Q2 2021 Earnings Call Transcript

ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…

Immunogen, Inc. (IMGN) Q1 2021 Earnings Call Transcript

Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…

ImmunoGen Inc. (IMGN) Q4 2020 Earnings Call Transcript

ImmunoGen Inc. (NASDAQ: IMGN) Q4 2020 earnings call dated Feb. 12, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…

Immunogen Inc (IMGN) Q3 2020 Earnings Call Transcript

Immunogen Inc  (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…